{"id":"tp-42605","type":"article-newspaper","title":"Biogen Raises 2026 EPS Guidance Floor as Growth Portfolio Expands","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/42605","datePublished":"2026-10-28T13:20:20.000Z","dateModified":"2026-10-28T13:20:20.000Z","language":"en","abstract":"The Growth Portfolio generated $1.26 billion, up 49% year over year, while multiple sclerosis product revenue fell 13% to $919 million.","section":"Business","references":[]}